Similarly, other studies showed 72.7% and 88% agreement between solid biopsy and liquid biopsy samples, respectively, in detecting EGFR mutations in ctDNA using qPCR in NSCLC patients (19, 20). Here, EGFR is linked to non-small cell lung carcinoma.